ITEM VIEW

Depression and anxiety in the developing world: Is it time to medicalise the suffering?

dc.contributor.authorStein D.J.
dc.contributor.authorGureje O.
dc.date.accessioned2011-05-15T15:57:03Z
dc.date.available2011-05-15T15:57:03Z
dc.date.issued2004
dc.identifier.citationLancet
dc.identifier.citation364
dc.identifier.citation9430
dc.identifier.issn1406736
dc.identifier.other10.1016/S0140-6736(04)16693-2
dc.identifier.urihttp://hdl.handle.net/10019.1/10185
dc.description.abstract[No abstract available]
dc.subjectfluoxetine
dc.subjectanxiety
dc.subjectcost effectiveness analysis
dc.subjectcounseling
dc.subjectdepression
dc.subjectdeveloping country
dc.subjectevidence based medicine
dc.subjecthealth care
dc.subjecthuman
dc.subjectmental disease
dc.subjectmental health
dc.subjectnote
dc.subjectposttraumatic stress disorder
dc.subjectpoverty
dc.subjectpriority journal
dc.subjectpsychotherapy
dc.subjecttreatment outcome
dc.subjectviolence
dc.subjectAnxiety
dc.subjectDepression
dc.subjectDeveloping Countries
dc.subjectHumans
dc.subjectPoverty
dc.subjectSocioeconomic Factors
dc.titleDepression and anxiety in the developing world: Is it time to medicalise the suffering?
dc.typeNote
dc.description.versionNote


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

ITEM VIEW